By Diagnostics World Staff
August 11, 2026 | Human Longevity last week announced the availability of Genomics for All, a clinical-grade whole genome sequencing product priced at $599. The offering sequences all 6.4 billion base pairs of an individual's DNA and delivers AI-interpreted results through the HLI app, with no clinic visit required.
Genomics for All sequences the entire genome at 30x clinical-grade depth and is capable of identifying inherited disease risk across more than 10,000 genetic variants, flagging pharmacogenomic markers that affect how individuals respond to common medications, and screening for carrier status in hereditary conditions. The report also covers health-related traits across nutrition, metabolism, and exercise response.
A central feature of the product is its AI-powered re-analysis capability. Because the genome itself does not change, HLI re-analyses each client's genomic data on an ongoing basis as new research is published, new disease-gene associations are identified, and clinical guidelines are updated. When a new clinically relevant finding emerges, HLI alerts affected clients, often within 24 hours of publication.
"Our founder Dr. Venter helped make it possible for humanity to read the human genome," said Wei-Wu He, Ph.D., Chairman and CEO of Human Longevity, in a press release. "With Genomics for All, we are continuing that vision by helping more people understand what their genome may mean for their long-term health. Our goal is not to replace physicians or make deterministic predictions, but to provide better information that can support more informed conversations, earlier awareness, and more personalized care."
Genomics for All sits within a broader AI-driven platform that HLI has been building for over a decade. In May 2026, HLI announced the launch of Human Life Foundation Models, Inc. (HLFM), a dedicated AI entity developed in partnership with Insilico Medicine. The multimillion-dollar collaboration aims to develop what the companies describe as the industry's first large-scale AI foundation model dedicated to longevity science, drawing on HLI's multimodal clinical and genomic datasets collected across more than 10,000 clients to identify the biological mechanisms of aging and enable predictive healthcare.
Genomics for All is the entry-level offering in HLI's broader suite of precision health programs, which also includes more comprehensive assessments combining advanced imaging, biomarker panels, and clinician-guided care.